000 | 01895 a2200553 4500 | ||
---|---|---|---|
005 | 20250517113523.0 | ||
264 | 0 | _c20180206 | |
008 | 201802s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.11733 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAbba, MartÃn C | |
245 | 0 | 0 |
_aDMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations. _h[electronic resource] |
260 |
_bOncotarget _cSep 2016 |
||
300 |
_a64289-64299 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _a9,10-Dimethyl-1,2-benzanthracene |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Transformation, Neoplastic _xchemically induced |
650 | 0 | 4 | _aClass I Phosphatidylinositol 3-Kinases |
650 | 0 | 4 | _aDNA Mutational Analysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xchemically induced |
650 | 0 | 4 | _aMedroxyprogesterone Acetate |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Inbred DBA |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPTEN Phosphohydrolase _xgenetics |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xgenetics |
650 | 0 | 4 |
_aRANK Ligand _xgenetics |
650 | 0 | 4 | _aSequence Analysis, RNA |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTranscriptome |
650 | 0 | 4 | _aExome Sequencing |
700 | 1 | _aZhong, Yi | |
700 | 1 | _aLee, Jaeho | |
700 | 1 | _aKil, Hyunsuk | |
700 | 1 | _aLu, Yue | |
700 | 1 | _aTakata, Yoko | |
700 | 1 | _aSimper, Melissa S | |
700 | 1 | _aGaddis, Sally | |
700 | 1 | _aShen, Jianjun | |
700 | 1 | _aAldaz, C Marcelo | |
773 | 0 |
_tOncotarget _gvol. 7 _gno. 39 _gp. 64289-64299 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.11733 _zAvailable from publisher's website |
999 |
_c26384420 _d26384420 |